A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomasManit Munshi(Dana-Farber Cancer Institute), Guang Yang(Harvard University)Blood AdvancesMarch 8, 202210.1182/bloodadvances.2021006147Cited by 15SaveCiteExport RISWatch citationsRelated PapersSYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas|Blood Cancer Journal|2020|44The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance|Blood|2021|28